Document is current
Any future updates will be listed below
-
Authors
Ogawa, Yukino
Miyoshi, Chika
Obana, Nozomu
Yajima, Kaho
Hotta-Hirashima, Noriko
Ikkyu, Aya
Kanno, Satomi
Soga, Tomoyoshi
Fukuda, Shinji
Yanagisawa, Masashi
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (19K14023, 18H04805, 17H06095)
Japan Science and Technology Agency (JPMJER1902)
Japan Agency for Medical Research and Development (JP19gm1010009)
the Takeda Science Foundation
the Food Science Institute Foundation
the Program for the Advancement of Research in Core Projects under Keio University’s Longevity Initiative
Ministry of Education, Culture, Sports, Science and Technology (A3A28043)
- License Information
-
More Information
Article History
Received: 13 June 2020
Accepted: 26 October 2020
First Online: 11 November 2020
Competing interests
: S.F. serves as CEO and holds equity in Metabologenomics Inc., a company involved in microbiome-based healthcare and drug discovery.
